Patients with MBD have abnormalities related to mineral metabolism (e.g., nonoptimal serum levels of phosphorus, calcium, parathyroid hormone (PTH); altered bone structure and composition; and extraskeletal calcification) [2]. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.